GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the fourth quarter and full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results